Fulgent Genetics (FLGT) Assets Average (2016 - 2026)

Fulgent Genetics has reported Assets Average for 11 years, with the latest figure at $1.1 billion in Q2 2026.

• Quarterly Assets Average fell 6.65% year-over-year to $1.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.1 billion (down 6.65% YoY) and the FY2025 annual result came in at $1.2 billion, down 0.89% from the prior year.
• Assets Average declined to $1.1 billion in Q2 2026 per FLGT's latest filing, from $1.2 billion in the prior quarter.
• Over five years, Assets Average peaked at $1.5 billion in Q2 2022 and troughed at $1.1 billion in Q2 2026.
• A 5-year average of $1.3 billion and a median of $1.2 billion in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2024: Assets Average soared 61.47% in 2022, then fell 10.77% in 2024.
• Over 5 years, Assets Average stood at $1.4 billion in 2022, then decreased by 7.1% to $1.3 billion in 2023, then slipped by 5.4% to $1.2 billion in 2024, then decreased by 1.04% to $1.2 billion in 2025, then dropped by 7.52% to $1.1 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $1.1 billion, $1.2 billion, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.